Skip to content
  • Home
  • About
    • Our mission
    • Partners
    • Network Activities
  • Centres
    • iMATCH
      • Overview
      • Activity
      • News
    • Midlands – Wales
      • Overview
      • Activity
      • News
    • Northern Alliance
      • Overview
      • Activity
      • News
  • News
  • Events
  • Resources
    • The CAR T-Cell Therapy Clinical Journey Guide
    • Case Studies
    • NHS Readiness Toolkit
    • Published Material
    • Webinars
  • NHS Readiness Toolkit
  • ATTC for patients
  • Network sign in

Advanced therapy education webinar series

Ian Hollingsworth2021-09-06T16:11:01+01:006th September 2021|Network, News|
Read More

MW-ATTC Advanced Therapies 2021 – An interactive series introducing cell and gene therapies

Jenny Needham2021-09-05T22:32:48+01:0011th August 2021|Midlands - Wales, News|
Read More
  • Instil Bio

Instil Bio list on the Nasdaq!

Vicky Sheard2021-04-16T10:00:07+01:0016th April 2021|News|
Read More

New gene therapy innovation centre to advance scientific discoveries into life-changing treatments

Pernille Woods2021-03-19T10:19:52+00:0019th March 2021|Midlands - Wales, News|
Read More

Orbsen Therapeutics and MW-ATTC collaboration supporting next phases of REALIST COVID-19 trial

Pernille Woods2021-01-29T09:30:49+00:0029th January 2021|Clinical Trials, Midlands - Wales, News|
Read More

Better education needed to give patients better understanding of gene therapies, new review highlights

Pernille Woods2020-12-08T16:53:36+00:008th December 2020|Midlands - Wales, News|
Read More

Future proofing the NHS with a unified ordering system for ATMPs

Ian Hollingsworth2020-10-02T16:10:08+01:002nd October 2020|Midlands - Wales, News|
Read More

Nitya’s Story – what is it like to receive CAR T cell therapy?

Pernille Woods2020-07-22T16:43:25+01:0022nd July 2020|Midlands - Wales, News|
Read More

New e-learning module on “Safe use of low temperature transport vessels” launched

Pernille Woods2020-07-03T12:00:17+01:003rd July 2020|Midlands - Wales, News|
Read More

First UK COVID19 patients treated with allogeneic cell therapy developed by ATTC Partner Orbsen Therapeutics

Edward Bywater2020-12-21T13:47:06+00:0021st April 2020|Midlands - Wales, News|
Read More
12Next
  • About
    • Our mission
    • Partners
    • Network Activities
  • Centres
    • Midlands – Wales
    • Northern Alliance
    • iMATCH
  • News
  • Events
  • Resources
    • The CAR T-Cell Therapy Clinical Journey Guide
    • NHS Readiness Toolkit Index
    • Webinars
    • Case Studies
    • Published Material
  • NHS Readiness Toolkit Index
  • Contact
  • Network sign in
  • Catapult UK

  • This project has been funded by the Industrial Strategy Challenge Fund, part of the government’s modern Industrial Strategy. The fund is delivered by UK Research and Innovation.

Privacy Policy Cookies
©ATTC 2020 Website by WeThink.

We only use third party cookies on this site. You can read more in our cookie policy.

ATTC Network - Advanced Therapy Treatment Centre
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Contact the author

Thank you. Your message has been sent to the author.